Global Antibiotics Market Size & Outlook, 2023-2030
Global antibiotics market, 2018-2030 (US$M)
Related Markets
Global antibiotics market highlights
- The global antibiotics market generated a revenue of USD 50,916.6 million in 2023 and is expected to reach USD 68,036.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 4.2% by 2030.
- In terms of segment, cell wall synthesis inhibitors accounted for a revenue of USD 26,542.1 million in 2023.
- RNA Synthesis Inhibitors is the most lucrative action mechanism segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, France is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 50,916.6 million |
| Market revenue in 2030 | USD 68,036.0 million |
| Growth rate | 4.2% (CAGR from 2023 to 2030) |
| Largest segment | Cell wall synthesis inhibitors |
| Fastest growing segment | RNA Synthesis Inhibitors |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors |
Other key industry trends
- In terms of revenue, the North America accounted for 28.7% of the global antibiotics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, France is the fastest growing regional market and is projected to reach USD 2,521.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotics Market Scope
Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotics market will help companies and investors design strategic landscapes.
Cell wall synthesis inhibitors was the largest segment with a revenue share of 52.13% in 2023. Horizon Databook has segmented the Global antibiotics market based on cell wall synthesis inhibitors, protein synthesis inhibitors, dna synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018-2030)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
- Global Antibiotics Type Outlook (Revenue, USD Million, 2018-2030)
- Branded Antibiotics
- Generic Antibiotics
- Global Antibiotics Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others
Reasons to subscribe to Global antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global antibiotics market databook
-
Our clientele includes a mix of antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global antibiotics market , including forecasts for subscribers. This global databook contains high-level insights into Global antibiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global antibiotics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Antibiotics market size, 2023 (US$M)
Global antibiotics market share, by action mechanism, 2023 & 2030 (%, US$M)
Antibiotics market: Opportunity assessment by country
Global antibiotics market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
